Eritropoyetina recombinante humana libre de albúmina. Su eficacia y tolerancia en pacientes con insuficiencia renal crónica en hemodiálisis
M. Alvarez Quiroga, A. Locatelli, R. Barone, L. de Benedetti y M. Gómez
Leído
6301
Vecesse ha leído el artículo
2164
Total PDF
4137
Total HTML
Información del artículo
ISSN: 02116995Idioma original: Español
Datos actualizados diariamente
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 71 | 74 | 145 |
| 2025 5 | 96 | 31 | 127 |
| 2025 4 | 87 | 28 | 115 |
| 2025 3 | 101 | 50 | 151 |
| 2025 2 | 102 | 39 | 141 |
| 2025 1 | 65 | 30 | 95 |
| 2024 12 | 58 | 20 | 78 |
| 2024 11 | 68 | 55 | 123 |
| 2024 10 | 56 | 33 | 89 |
| 2024 9 | 51 | 23 | 74 |
| 2024 8 | 58 | 44 | 102 |
| 2024 7 | 52 | 26 | 78 |
| 2024 6 | 69 | 34 | 103 |
| 2024 5 | 81 | 38 | 119 |
| 2024 4 | 61 | 24 | 85 |
| 2024 3 | 42 | 22 | 64 |
| 2024 2 | 55 | 29 | 84 |
| 2024 1 | 65 | 32 | 97 |
| 2023 12 | 47 | 33 | 80 |
| 2023 11 | 30 | 30 | 60 |
| 2023 10 | 46 | 27 | 73 |
| 2023 9 | 47 | 21 | 68 |
| 2023 8 | 49 | 16 | 65 |
| 2023 7 | 64 | 35 | 99 |
| 2023 6 | 125 | 24 | 149 |
| 2023 5 | 124 | 32 | 156 |
| 2023 4 | 44 | 20 | 64 |
| 2023 3 | 66 | 30 | 96 |
| 2023 2 | 43 | 24 | 67 |
| 2022 1 | 48 | 22 | 70 |
| 2022 12 | 28 | 36 | 64 |
| 2022 11 | 55 | 33 | 88 |
| 2022 10 | 67 | 37 | 104 |
| 2022 9 | 55 | 35 | 90 |
| 2022 8 | 62 | 35 | 97 |
| 2022 7 | 55 | 41 | 96 |
| 2022 6 | 39 | 32 | 71 |
| 2022 5 | 23 | 32 | 55 |
| 2022 4 | 45 | 45 | 90 |
| 2022 3 | 40 | 37 | 77 |
| 2022 2 | 48 | 34 | 82 |
| 2021 1 | 36 | 47 | 83 |
| 2021 12 | 36 | 33 | 69 |
| 2021 11 | 28 | 50 | 78 |
| 2021 10 | 53 | 56 | 109 |
| 2021 9 | 45 | 32 | 77 |
| 2021 8 | 41 | 50 | 91 |
| 2021 7 | 20 | 37 | 57 |
| 2021 6 | 29 | 14 | 43 |
| 2021 5 | 26 | 16 | 42 |
| 2021 4 | 34 | 23 | 57 |
| 2021 3 | 48 | 35 | 83 |
| 2021 2 | 58 | 29 | 87 |
| 2020 1 | 20 | 18 | 38 |
| 2020 12 | 34 | 9 | 43 |
| 2020 11 | 30 | 6 | 36 |
| 2020 10 | 18 | 9 | 27 |
| 2020 9 | 37 | 11 | 48 |
| 2020 8 | 11 | 4 | 15 |
| 2020 7 | 20 | 10 | 30 |
| 2020 6 | 47 | 19 | 66 |
| 2020 5 | 32 | 18 | 50 |
| 2020 4 | 16 | 14 | 30 |
| 2020 3 | 15 | 8 | 23 |
| 2020 2 | 29 | 17 | 46 |
| 2020 1 | 36 | 24 | 60 |
| 2019 12 | 19 | 11 | 30 |
| 2019 11 | 23 | 2 | 25 |
| 2019 10 | 25 | 11 | 36 |
| 2019 9 | 25 | 24 | 49 |
| 2019 8 | 21 | 18 | 39 |
| 2019 7 | 11 | 14 | 25 |
| 2019 6 | 9 | 8 | 17 |
| 2019 5 | 12 | 35 | 47 |
| 2019 4 | 45 | 48 | 93 |
| 2019 3 | 20 | 13 | 33 |
| 2019 2 | 15 | 9 | 24 |
| 2019 1 | 15 | 10 | 25 |
| 2018 12 | 23 | 12 | 35 |
| 2018 11 | 20 | 2 | 22 |
| 2018 10 | 18 | 0 | 18 |
| 2018 9 | 18 | 1 | 19 |
| 2018 8 | 7 | 0 | 7 |
| 2018 7 | 7 | 1 | 8 |
| 2018 6 | 20 | 0 | 20 |
| 2018 5 | 15 | 1 | 16 |
| 2018 4 | 7 | 0 | 7 |
| 2018 3 | 7 | 0 | 7 |
| 2018 2 | 5 | 0 | 5 |
| 2018 1 | 4 | 1 | 5 |
| 2017 12 | 10 | 1 | 11 |
| 2017 11 | 7 | 1 | 8 |
| 2017 10 | 6 | 0 | 6 |
| 2017 9 | 4 | 0 | 4 |
| 2017 8 | 5 | 0 | 5 |
| 2017 7 | 5 | 1 | 6 |
| 2017 6 | 4 | 0 | 4 |
| 2017 5 | 2 | 1 | 3 |
| 2017 4 | 3 | 0 | 3 |
| 2017 3 | 10 | 0 | 10 |
| 2017 2 | 1 | 0 | 1 |
| 2016 1 | 5 | 2 | 7 |
| 2016 12 | 11 | 0 | 11 |
| 2016 11 | 11 | 0 | 11 |
| 2016 10 | 26 | 0 | 26 |
| 2016 9 | 8 | 0 | 8 |
| 2016 8 | 19 | 0 | 19 |
| 2016 7 | 40 | 5 | 45 |
| 2016 6 | 35 | 0 | 35 |
| 2016 5 | 45 | 0 | 45 |
| 2016 4 | 31 | 0 | 31 |
| 2016 3 | 22 | 0 | 22 |
| 2016 2 | 9 | 0 | 9 |
| 2015 1 | 12 | 0 | 12 |
| 2015 12 | 21 | 0 | 21 |
| 2015 11 | 15 | 0 | 15 |
| 2015 10 | 15 | 0 | 15 |
| 2015 9 | 12 | 0 | 12 |
| 2015 8 | 11 | 0 | 11 |
| 2015 7 | 14 | 0 | 14 |
| 2015 6 | 10 | 0 | 10 |
| 2015 5 | 30 | 0 | 30 |
Mostrar todo
